adamantane has been researched along with Chagas Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Barrias, E; Calogeropoulou, T; de Souza, W; Reignault, LC | 1 |
Benaim, G; Galindo, I; Gil, Z; Martinez, JC; Martinez-Sotillo, N; Mejias, F; Oldfield, E; Pinto-Martinez, A | 1 |
Benaim, G; de Carvalho, TM; de Souza, W; Docampo, R; Galizzi, M; Gonzalez-Pacanowska, D; Guo, RT; Hernandez-Rodriguez, V; Huang, G; Lameira, L; Li, K; Li, Q; Oldfield, E; Shang, N; Urbina, JA; Veiga-Santos, P | 1 |
3 other study(ies) available for adamantane and Chagas Disease
Article | Year |
---|---|
In vitro activities of adamantylidene-substituted alkylphosphocholine TCAN26 against Trypanosoma cruzi: Antiproliferative and ultrastructural effects.
Topics: Adamantane; Animals; Antiprotozoal Agents; Autophagy; Cell Membrane; Chagas Disease; Dose-Response Relationship, Drug; Flow Cytometry; Golgi Apparatus; Inhibitory Concentration 50; Lethal Dose 50; Macrophages, Peritoneal; Mice; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Microscopy, Immunoelectron; Mitochondria; Phosphorylcholine; Trypanocidal Agents; Trypanosoma cruzi | 2019 |
SQ109 inhibits proliferation of Leishmania donovani by disruption of intracellular Ca
Topics: Adamantane; Animals; Cell Proliferation; Chagas Disease; Cytoplasm; Ethylenediamines; Humans; Leishmania donovani; Leishmania mexicana; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Macrophages; Membrane Potential, Mitochondrial; Mitochondria; Trypanosoma cruzi | 2020 |
SQ109, a new drug lead for Chagas disease.
Topics: Adamantane; Animals; Chagas Disease; Ethylenediamines; Hemolysis; Humans; In Vitro Techniques; LLC-PK1 Cells; Membrane Potential, Mitochondrial; Squalene; Sterols; Swine; Triazoles; Trypanocidal Agents; Trypanosoma cruzi | 2015 |